scholarly article | Q13442814 |
P2093 | author name string | A J Levine | |
S Jin | |||
P433 | issue | Pt 23 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 2 | |
P304 | page(s) | 4139-4140 | |
P577 | publication date | 2001-12-01 | |
P1433 | published in | Journal of Cell Science | Q1524177 |
P1476 | title | The p53 functional circuit | |
P478 | volume | 114 |
Q34626391 | A functional polymorphism T309G in MDM2 gene promoter, intensified by Helicobacter pylori lipopolysaccharide, is associated with both an increased susceptibility and poor prognosis of gastric carcinoma in Chinese patients |
Q34414191 | A novel proteasome inhibitor acting in mitochondrial dysfunction, ER stress and ROS production |
Q34063417 | A plausible model for the digital response of p53 to DNA damage. |
Q54405168 | Analysis of differential gene expression by fiber-optic BeadArray and pathway in prolactinomas. |
Q39954141 | Apoptosis and autophagy induction in mammalian cells by small interfering RNA knockdown of mRNA capping enzymes |
Q37011615 | Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2. |
Q92914776 | Assessment of acyl-CoA cholesterol acyltransferase (ACAT-1) role in ovarian cancer progression-An in vitro study |
Q37445665 | Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population |
Q41162286 | Association between p53 Pro72Arg polymorphism and prostate cancer risk: a meta-analysis |
Q37522376 | BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53. |
Q35613930 | BLIMP1 regulates cell growth through repression of p53 transcription. |
Q39895118 | CIAP1 and the serine protease HTRA2 are involved in a novel p53-dependent apoptosis pathway in mammals. |
Q37215916 | Caveolin-1 regulates the antagonistic pleiotropic properties of cellular senescence through a novel Mdm2/p53-mediated pathway |
Q50089286 | Chemoprevention by Probiotics During 1,2-Dimethylhydrazine-Induced Colon Carcinogenesis in Rats |
Q28386766 | Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore |
Q33987511 | DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence |
Q39247204 | DNA damage-induced phosphatase Wip1 in regulation of hematopoiesis, immune system and inflammation |
Q34353609 | DNA polymerase eta, the product of the xeroderma pigmentosum variant gene and a target of p53, modulates the DNA damage checkpoint and p53 activation. |
Q41141267 | Differential p53 engagement in response to oxidative and oncogenic stresses in Fanconi anemia mice |
Q35626028 | Differential programming of p53-deficient embryonic cells during rotenone block. |
Q33593066 | Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations |
Q28077156 | Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness |
Q36507446 | Ethanol extract of paeonia suffruticosa Andrews (PSE) induced AGS human gastric cancer cell apoptosis via fas-dependent apoptosis and MDM2-p53 pathways |
Q34266062 | Evolutionary conservation and network structure characterize genes of phenotypic relevance for mitosis in human |
Q36380474 | Exercise-induced lung cancer regression: mechanistic findings from a mouse model |
Q28391168 | Exit from arsenite-induced mitotic arrest is p53 dependent |
Q36128004 | Faster DNA Repair of Ultraviolet-Induced Cyclobutane Pyrimidine Dimers and Lower Sensitivity to Apoptosis in Human Corneal Epithelial Cells than in Epidermal Keratinocytes |
Q46234676 | Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2. |
Q34606453 | Glycyrrhizic acid suppresses the development of precancerous lesions via regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats |
Q26746946 | HCV-Induced Oxidative Stress: Battlefield-Winning Strategy |
Q35721519 | Haplotype structure and selection of the MDM2 oncogene in humans |
Q39344424 | Harmonic oscillations in homeostatic controllers: Dynamics of the p53 regulatory system |
Q42410819 | High level of COP1 expression is associated with poor prognosis in primary gastric cancer |
Q34496093 | Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death |
Q39390180 | Huntington's Disease and Mitochondria |
Q64111946 | Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value |
Q33529063 | Immunohistochemistry in diagnostic surgical pathology: contributions of protein life-cycle, use of evidence-based methods and data normalization on interpretation of immunohistochemical stains. |
Q34501597 | Impact of p73 gene polymorphism on cancer susceptibility: a meta analysis. |
Q36858555 | Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells. |
Q39113758 | Involvement of CD137 ligand signaling in neural stem cell death |
Q38720731 | Iodine-131 treatment of thyroid cancer cells leads to suppression of cell proliferation followed by induction of cell apoptosis and cell cycle arrest by regulation of B-cell translocation gene 2-mediated JNK/NF-κB pathways |
Q38162722 | Ionizing radiation-induced responses in human cells with differing TP53 status |
Q34653644 | Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies |
Q36905850 | Lanatoside C suppressed colorectal cancer cell growth by inducing mitochondrial dysfunction and increased radiation sensitivity by impairing DNA damage repair |
Q35726053 | Loss of DDB1 Leads to Transcriptional p53 Pathway Activation in Proliferating Cells, Cell Cycle Deregulation, and Apoptosis in Zebrafish Embryos. |
Q39868313 | MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. |
Q39205410 | MDM2 is a useful prognostic biomarker for resectable gastric cancer |
Q40088470 | MDM2 promoter del1518 polymorphism and cancer risk: evidence from 22,931 subjects. |
Q34766227 | Mechanisms that enhance sustainability of p53 pulses |
Q27316420 | Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis |
Q28397039 | Modeling gene expression regulatory networks with the sparse vector autoregressive model |
Q35872435 | Multiple target drug cocktail design for attacking the core network markers of four cancers using ligand-based and structure-based virtual screening methods |
Q37216681 | Oxidative stress in Fanconi anemia hematopoiesis and disease progression |
Q61449898 | PDCD4 Knockdown Induces Senescence in Hepatoma Cells by Up-Regulating the p21 Expression |
Q64075446 | Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis |
Q33862413 | Phosphoinositide phosphatases in cell biology and disease |
Q35309216 | Polymerase I and transcript release factor (PTRF)/cavin-1 is a novel regulator of stress-induced premature senescence |
Q37293815 | Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment |
Q35048287 | Polymorphisms of MDM4 and risk of squamous cell carcinoma of the head and neck |
Q34464794 | Potential therapeutic role of Tridham in human hepatocellular carcinoma cell line through induction of p53 independent apoptosis |
Q36945832 | Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma |
Q37119578 | Progressive apoptosis resistance prior to senescence and control by the anti-apoptotic protein BCL-xL. |
Q30505355 | Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 induction |
Q34865488 | Proper expression of the Gcn5 histone acetyltransferase is required for neural tube closure in mouse embryos. |
Q35512805 | Qualitative network modeling of the Myc-p53 control system of cell proliferation and differentiation |
Q34658158 | Rapid detection of SNP (c.309T>G) in the MDM2 gene by the Duplex SmartAmp method |
Q36509230 | Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage |
Q99582344 | Relationship between Chromosomal Aberrations and Gene Expressions in the p53 Pathway in Chronic Lymphocytic Leukemia |
Q33640598 | SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization |
Q39269601 | Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome |
Q55617693 | Significant Association of the MDM2 T309G Polymorphism with Breast Cancer Risk in a Turkish Population |
Q39868832 | Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells |
Q33932445 | Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk |
Q39899035 | Soft-shell clam (Mya arenaria) p53: a structural and functional comparison to human p53. |
Q35111567 | Study of the Anti-Proliferative Activity of 5-Substituted 4,7-Dimethoxy-1,3-Benzodioxole Derivatives of SY-1 from Antrodia camphorata on Human COLO 205 Colon Cancer Cells |
Q34559185 | TP53 mutations in nonsmall cell lung cancer |
Q37644979 | The Fanconi anemia pathway controls oncogenic response in hematopoietic stem and progenitor cells by regulating PRMT5-mediated p53 arginine methylation |
Q48566014 | The Ubiquitin Ligase COP1 Promotes Glioma Cell Proliferation by Preferentially Downregulating Tumor Suppressor p53. |
Q33840457 | The coordinate regulation of the p53 and mTOR pathways in cells |
Q55461230 | The effects of p53 Arg72Pro polymorphism on glioma susceptibility: a meta-analysis. |
Q33724426 | The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerases II and III independently of sequence-specific DNA binding |
Q34064408 | The p53MH algorithm and its application in detecting p53-responsive genes |
Q36161258 | The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability |
Q26865749 | The significance of genetics for cholangiocarcinoma development |
Q36833275 | Therapeutic targeting of the p53 pathway in cancer stem cells. |
Q34121104 | Tissue-specific and age-dependent effects of global Mdm2 loss |
Q54977441 | Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why. |
Q37156031 | Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia |
Q37708317 | Wnt signalling and the control of cellular metabolism. |
Q36265845 | miR-23a binds to p53 and enhances its association with miR-128 promoter |
Q37203736 | p53 Mediates Colistin-Induced Autophagy and Apoptosis in PC-12 Cells |
Q34670488 | p53 Pro72Arg polymorphism and prostate cancer in men of African descent |
Q34708448 | p53 Represses transcription of RING finger LIM domain-binding protein RLIM through Sp1 |
Q53286606 | p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study. |
Q38704009 | p53 responsive elements in human retrotransposons. |
Q42925815 | p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor |
Search more.